Literature DB >> 22385964

A differentiation checkpoint limits hematopoietic stem cell self-renewal in response to DNA damage.

Jianwei Wang1, Qian Sun, Yohei Morita, Hong Jiang, Alexander Gross, André Lechel, Kai Hildner, Luis Miguel Guachalla, Anne Gompf, Daniel Hartmann, Axel Schambach, Torsten Wuestefeld, Daniel Dauch, Hubert Schrezenmeier, Wolf-Karsten Hofmann, Hiromitsu Nakauchi, Zhenyu Ju, Hans A Kestler, Lars Zender, K Lenhard Rudolph.   

Abstract

Checkpoints that limit stem cell self-renewal in response to DNA damage can contribute to cancer protection but may also promote tissue aging. Molecular components that control stem cell responses to DNA damage remain to be delineated. Using in vivo RNAi screens, we identified basic leucine zipper transcription factor, ATF-like (BATF) as a major component limiting self-renewal of hematopoietic stem cells (HSCs) in response to telomere dysfunction and γ-irradiation. DNA damage induces BATF in a G-CSF/STAT3-dependent manner resulting in lymphoid differentiation of HSCs. BATF deletion improves HSC self-renewal and function in response to γ-irradiation or telomere shortening but results in accumulation of DNA damage in HSCs. Analysis of bone marrow from patients with myelodysplastic syndrome supports the conclusion that DNA damage-dependent induction of BATF is conserved in human HSCs. Together, these results provide experimental evidence that a BATF-dependent differentiation checkpoint limits self-renewal of HSCs in response to DNA damage. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22385964     DOI: 10.1016/j.cell.2012.01.040

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  156 in total

Review 1.  Autophagy in stem and progenitor cells.

Authors:  Carlo Rodolfo; Sabrina Di Bartolomeo; Francesco Cecconi
Journal:  Cell Mol Life Sci       Date:  2015-10-26       Impact factor: 9.261

Review 2.  Accumulation of DNA damage in the aged hematopoietic stem cell compartment.

Authors:  Isabel Beerman
Journal:  Semin Hematol       Date:  2016-11-18       Impact factor: 3.851

Review 3.  Understanding telomere diseases through analysis of patient-derived iPS cells.

Authors:  Luis F Z Batista; Steven E Artandi
Journal:  Curr Opin Genet Dev       Date:  2013-08-28       Impact factor: 5.578

4.  Common and Differential Transcriptional Actions of Nuclear Receptors Liver X Receptors α and β in Macrophages.

Authors:  Ana Ramón-Vázquez; Juan Vladimir de la Rosa; Carlos Tabraue; Felix Lopez; Bonifacio Nicolas Díaz-Chico; Lisardo Bosca; Peter Tontonoz; Susana Alemany; Antonio Castrillo
Journal:  Mol Cell Biol       Date:  2019-02-15       Impact factor: 4.272

Review 5.  DNA damage response, redox status and hematopoiesis.

Authors:  Cary N Weiss; Keisuke Ito
Journal:  Blood Cells Mol Dis       Date:  2013-09-13       Impact factor: 3.039

6.  Epigenomics of human CD8 T cell differentiation and aging.

Authors:  David M Moskowitz; David W Zhang; Bin Hu; Sabine Le Saux; Rolando E Yanes; Zhongde Ye; Jason D Buenrostro; Cornelia M Weyand; William J Greenleaf; Jörg J Goronzy
Journal:  Sci Immunol       Date:  2017-02-17

7.  Quiescent hematopoietic stem cells accumulate DNA damage during aging that is repaired upon entry into cell cycle.

Authors:  Isabel Beerman; Jun Seita; Matthew A Inlay; Irving L Weissman; Derrick J Rossi
Journal:  Cell Stem Cell       Date:  2014-05-08       Impact factor: 24.633

Review 8.  Molecular pathophysiology of the myelodysplastic syndromes: insights for targeted therapy.

Authors:  Alex Aleshin; Peter L Greenberg
Journal:  Blood Adv       Date:  2018-10-23

9.  The immune receptor Trem1 cooperates with diminished DNA damage response to induce preleukemic stem cell expansion.

Authors:  W Du; S Amarachintha; A Wilson; Q Pang
Journal:  Leukemia       Date:  2016-08-29       Impact factor: 11.528

Review 10.  Mechanisms of BRCA1 tumor suppression.

Authors:  Daniel P Silver; David M Livingston
Journal:  Cancer Discov       Date:  2012-07-27       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.